Phase 4 Crohn's Disease and Colitis Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The child or teenager must be between 6 and 17 years old (any gender).
- They must have been diagnosed with moderate to severe active Crohn's disease in children, based on specific medical guidelines from 2019.
- Their doctor must have already decided, after carefully weighing the risks and benefits, that Adalimumab injection (a specific medication) is the right treatment for them.
- Both the patient and their parent or guardian must agree to take part and sign a consent form that meets local legal requirements.
Who may not be able to join:
- If the treating doctor believes, based on the medication's guidelines, that Adalimumab injection is not appropriate for the child, they cannot join.
- Children who have received any live vaccines (a type of vaccine that uses a weakened live virus) in the 3 months before starting the medication, or who plan to receive any live vaccines during the study, cannot join.
- Children who are already taking part in another clinical trial cannot join.
- Children who the trial doctor feels are not suitable for any other reason cannot join (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18902268612
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
The incidence of adverse events (AE), adverse drug reactions (ADR), adverse events of special interest (AESI) and serious ADR at 12, 26 and 52 weeks after treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.